- Home
- GCT vs IMTX Comparison
GCT vs IMTX Comparison
Compare GCT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GCT | IMTX |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GCT | IMTX |
|---|---|---|
| Price | $35.23 | $10.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $24.00 | $19.25 |
| AVG Volume (30 Days) | ★ 465.8K | 342.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.61 | N/A |
| EPS | ★ 2.56 | N/A |
| Revenue | ★ $1,161,042,000.00 | N/A |
| Revenue This Year | $9.56 | N/A |
| Revenue Next Year | $7.08 | $19.39 |
| P/E Ratio | $13.82 | ★ N/A |
| Revenue Growth | ★ 64.96 | N/A |
| 52 Week Low | $11.17 | $3.30 |
| 52 Week High | $44.71 | $12.41 |
Technical Indicators
Market Signals| Indicator | GCT | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 51.12 |
| Support Level | $33.47 | $9.75 |
| Resistance Level | $36.18 | $10.42 |
| Average True Range (ATR) | 1.89 | 0.69 |
| MACD | -0.49 | 0.05 |
| Stochastic Oscillator | 15.24 | 70.50 |
Price Performance
Historical ComparisonAbout GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.